Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells

References

• Allemani, C., et al., 2018. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population. Lancet, 391 (10125), 1023–1075.
   PubMed Web of Science ®Google Scholar
• Anand, P., et al., 2008. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer letters, 267 (1), 133–164.
   PubMed Web of Science ®Google Scholar
• Barton, D., et al., 1997. Angiogenic protein expression in advanced epithelial ovarian cancer. Clinical cancer research: an official journal of the American Association for Cancer Research, 3 (9), 1579–1586.
   PubMed Web of Science ®Google Scholar
• Califano, D., et al., 2021. Evaluation of angiogenesis-related genes as prognostic biomarkers of bevacizumab treated ovarian cancer patients: results from the phase IV MITO16A/ManGO OV-2 translational study. Cancers, 13 (20), 5152.
   PubMed Web of Science ®Google Scholar
• Che, Y., et al., 2015. The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis. Cancer letters, 359 (2), 241–249.
   PubMed Web of Science ®Google Scholar
• Chiang, Y.C., Lin, P.H., and Cheng, W.F., 2021. Homologous recombination deficiency assays in epithelial ovarian cancer: current status and future direction. Frontiers in oncology, 11, 675972.
   PubMed Web of Science ®Google Scholar
• Du Bois, A., et al., 2009. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d‘Investigateurs Nationaux Pour les Etudes des Cancers de l‘Ovaire (GINECO). Cancer, 115 (6), 1234–1244.
   PubMed Web of Science ®Google Scholar
• Duncanson, W.J., et al., 2007. Targeted binding of PLA microparticles with lipid-PEG-tethered ligands. Biomaterials, 28 (33), 4991–4999.
   PubMed Web of Science ®Google Scholar
• Dutta, S., et al., 2011. The NF-kappaB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC). Gynecologic oncology, 123 (1), 129–137.
   PubMed Web of Science ®Google Scholar
• Garrido, M.P., et al., 2020. Metformin reduces NGF-induced tumour promoter effects in epithelial ovarian cancer cells. Pharmaceuticals, 13 (10), 315.
   Web of Science ®Google Scholar
• Goldar, S., et al., 2015. Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pacific journal of cancer prevention: APJCP, 16 (6), 2129–2144.
   PubMedGoogle Scholar
• Guo, H., et al., 2017. Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization. Oncogene, 36 (36), 5098–5109.
   PubMed Web of Science ®Google Scholar
• Gupta, S., et al., 2019. Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives - a review. Journal of ovarian research, 12 (1), 103.
   PubMed Web of Science ®Google Scholar
• He, L., et al., 2019. Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis. Theranostics, 9 (26), 8206–8220.
   PubMed Web of Science ®Google Scholar
• Hiss, D., 2012. Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways. Journal of oncology, 2012, 737981.
   PubMedGoogle Scholar
• Hu, J., et al., 2019. Effect of acupoint therapies on chemotherapy-induced nausea and vomiting: a systematic review protocol. Medicine, 98 (37), e17109.
   PubMed Web of Science ®Google Scholar
• Huang, T., et al., 2018. Epirubicin induces apoptosis in osteoblasts through death-receptor and mitochondrial pathways. Apoptosis: an international journal on programmed cell death, 23 (3-4), 226–236.
   PubMed Web of Science ®Google Scholar
• Itatani, Y., et al., 2018. Resistance to anti-angiogenic therapy in cancer-alterations to anti-VEGF pathway. International journal of molecular sciences, 19 (4), 1232.
   PubMed Web of Science ®Google Scholar
• Iwasaki, K., et al., 2015. A fluorescent imaging probe based on a macrocyclic scaffold that binds to cellular EpCAM. Journal of molecular evolution, 81 (5-6), 210–217.
   PubMed Web of Science ®Google Scholar
• Jin, M., et al., 2018. Successful maintenance therapy with apatinib inplatinum-resistant advanced ovarian cancer and literature review. Cancer biology & therapy, 19 (12), 1088–1092.
   PubMed Web of Science ®Google Scholar
• Ju, R.J., et al., 2014. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer. Biomaterials, 35 (26), 7610–7621.
   PubMed Web of Science ®Google Scholar
• Jung, S., et al., 2010. Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes. Colloids and surfaces. B, biointerfaces, 76 (2), 434–440.
   PubMed Web of Science ®Google Scholar
• Kamat, A.A., et al., 2006. The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Clinical cancer research: an official journal of the American Association for Cancer Research, 12 (6), 1707–1714.
   PubMed Web of Science ®Google Scholar
• Lambert, A., Pattabiraman, D., and Weinberg, R., 2017. Emerging biological principles of metastasis. Cell, 168 (4), 670–691.
   PubMed Web of Science ®Google Scholar
• Lee, J.S., Hwang, S.Y., and Lee, E.K., 2015. Imaging-based analysis of liposome internalization to macrophage cells: effects of liposome size and surface modification with PEG moiety. Colloids and surfaces. B, biointerfaces, 136, 786–790.
   PubMed Web of Science ®Google Scholar
• Lheureux, S., Braunstein, M., and Oza, A.M., 2019. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA: a cancer journal for clinicians, 69 (4), 280–304.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2021. Enhanced antitumour efficiency of RGD-modified epirubicin plus tetrandrine liposomes in treatment of gastric cancer via inhibiting tumour metastasis. Journal of liposome research, 31 (2), 145–157.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2020. Nanoparticles in precision medicine for ovarian cancer: from chemotherapy to immunotherapy. International journal of pharmaceutics, 591, 119986.
   PubMed Web of Science ®Google Scholar
• Lim, D., et al., 2020. Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer. BMB reports, 53 (6), 291–298.
   PubMed Web of Science ®Google Scholar
• Liu, C.Z., et al., 2012. Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer. Chinese journal of cancer research = Chung-Kuo Yen Cheng Yen Chiu, 24 (2), 130–137.
   PubMed Web of Science ®Google Scholar
• Lokadasan, R., et al., 2016. Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments. Ecancermedicalscience, 10, 626.
   PubMedGoogle Scholar
• Maetzel, D., et al., 2009. Nuclear signalling by tumour-associated antigen EpCAM. Nature cell biology, 11 (2), 162–171.
   PubMed Web of Science ®Google Scholar
• Maniotis, A.J., et al., 1999. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. The American journal of pathology, 155 (3), 739–752.
   PubMed Web of Science ®Google Scholar
• Mao, G., et al., 2015. Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer. Angiogenesis, 18 (3), 373–382.
   PubMed Web of Science ®Google Scholar
• Miller, E.M., Samec, T.M., and Alexander-Bryant, A.A., 2021. Nanoparticle delivery systems to combat drug resistance in ovarian cancer. Nanomedicine : nanotechnology, biology, and medicine, 31, 102309.
   PubMed Web of Science ®Google Scholar
• Mortezaee, K., et al., 2019. Mechanisms of apoptosis modulation by curcumin: implications for cancer therapy. Journal of cellular physiology, 234 (8), 12537–12550.
   PubMed Web of Science ®Google Scholar
• Murphy, A.D., et al., 2022. The role of vascular endothelial growth factor inhibitors in the treatment of epithelial ovarian cancer. British journal of cancer, 126 (6), 851–864.
   PubMed Web of Science ®Google Scholar
• Muynck, L., et al., 2020. Novel molecular targets for tumor-specific imaging of epithelial ovarian cancer metastases. Cancers, 12 (6), 1562.
   PubMed Web of Science ®Google Scholar
• Nunna, S., et al., 2014. Targeted methylation of the epithelial cell adhesion molecule (EpCAM) promoter to silence its expression in ovarian cancer cells. PLoS one, 9 (1), e87703.
   PubMed Web of Science ®Google Scholar
• Park, J.Y., et al., 2018. Eupatilin inhibits angiogenesis-mediated human hepatocellular metastasis by reducing MMP-2 and VEGF signaling. Bioorganic & medicinal chemistry letters, 28 (19), 3150–3154.
   PubMed Web of Science ®Google Scholar
• Prea, S.M., et al., 2015. Gene therapy with endogenous inhibitors of angiogenesis for neovascular age-related macular degeneration: beyond anti-VEGF therapy. Journal of ophthalmology, 2015, 201726.
   PubMed Web of Science ®Google Scholar
• Qian, C.N. and Pezzella, F., 2018. Tumor vasculature: a sally port for inhibiting cancer cell spreading. Cancer communications, 38 (1), 52.
   Google Scholar
• Reid, B.M., Permuth, J.B., and Sellers, T.A., 2017. Epidemiology of ovarian cancer: a review. Cancer biology & medicine, 14 (1), 9–32.
   PubMed Web of Science ®Google Scholar
• Rui Liu, C.L., et al., 2022. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chinese chemical letters, 33, 1001–8417.
   Google Scholar
• Sakurai, Y., et al., 2017. Efficient siRNA delivery by lipid nanoparticles modified with a nonstandard macrocyclic peptide for EpCAM-targeting. Molecular pharmaceutics, 14 (10), 3290–3298.
   PubMed Web of Science ®Google Scholar
• Shehzad, A., Lee, J., and Lee, Y., 2013. Curcumin in various cancers. BioFactors, 39 (1), 56–68.
   PubMed Web of Science ®Google Scholar
• Sung, H., et al., 2021. Global cancer statistics 20120: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 71 (3), 209–249.
   PubMed Web of Science ®Google Scholar
• Talmadge, J.E. and Fidler, I.J., 2010. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer research, 70 (14), 5649–5669.
   PubMed Web of Science ®Google Scholar
• Tavsan, Z. and Ayar Kayali, H., 2020. EpCAM-claudin-tetraspanin-modulated ovarian cancer progression and drug resistance. Cell adhesion & migration, 14 (1), 57–68.
   PubMed Web of Science ®Google Scholar
• Terlikowska, K.M., et al., 2014. Potential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer. International journal of molecular sciences, 15 (12), 21703–21722.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2019. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer. Acta biomaterialia, 94, 495–504.
   PubMed Web of Science ®Google Scholar
• Wen, N., et al., 2014. Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer. Journal of translational medicine, 12, 134.
   PubMed Web of Science ®Google Scholar
• Wi, T., et al., 2020. Efficacy of combination therapy with linalool and doxorubicin encapsulated by liposomes as a two-in-one hybrid carrier system for epithelial ovarian carcinoma. International journal of nanomedicine, 15, 8427–8436.
   PubMed Web of Science ®Google Scholar
• Wong, R.S., 2011. Apoptosis in cancer: from pathogenesis to treatment. Journal of experimental & clinical cancer research, 30 (1), 87.
   PubMed Web of Science ®Google Scholar
• Xin, X., et al., 2021. Efficient anti-glioma therapy through the brain-targeted RVG15-modified liposomes loading paclitaxel-cholesterol complex. International journal of nanomedicine, 16, 5755–5776.
   PubMed Web of Science ®Google Scholar
• Xu, L., et al., 2014. Epirubicin directly promotes hepatitis B virus (HBV) replication in stable HBV-expressing cell lines: a novel mechanism of HBV reactivation following anticancer chemotherapy. Molecular medicine reports, 9 (4), 1345–1350.
   PubMed Web of Science ®Google Scholar
• Yallapu, M., Jaggi, M., and Chauhan, S., 2013. Curcumin nanomedicine: a road to cancer therapeutics. Current pharmaceutical design, 19 (11), 1994–2010.
   PubMed Web of Science ®Google Scholar
• Yan, Z., et al., 2017. Title prognosis significance of ZEB2 and TGF-β1 as well as other clinical characteristics in epithelial ovarian cancer. International journal of gynecological cancer: official journal of the international gynecological cancer society, 27 (7), 1343–1349.
   PubMed Web of Science ®Google Scholar
• Yang, M.H., et al., 2008. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nature cell biology, 10 (3), 295–305.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2017. Discovery and evaluation of triple inhibitors of VEGFR-2, TIE-2 and EphB4 as anti-angiogenic and anti-cancer agents. Oncotarget, 8 (62), 104745–104760.
   PubMedGoogle Scholar
• Zhao, M.D., et al., 2019. Co-delivery of curcumin and paclitaxel by "core-shell" targeting amphiphilic copolymer to reverse resistance in the treatment of ovarian cancer. International journal of nanomedicine, 14, 9453–9467.
   PubMed Web of Science ®Google Scholar
• Zheng, J., et al., 2017. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma. Open medicine, 12, 39–44.
   Web of Science ®Google Scholar
• Zununi Vahed, S., et al., 2017. Liposome-based drug co-delivery systems in cancer cells. Materials science & engineering. C, materials for biological applications, 71, 1327–1341.
   PubMed Web of Science ®Google Scholar